Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study

BACKGROUND: Alzheimer’s disease is a devastating neurodegenerative disorder. Its worldwide prevalence is over 24 million and is expected to double by 2040. Finding ways to prevent its cognitive decline is urgent. METHODS: A two-sample Mendelian randomization study was performed instrumenting glutami...

Descripción completa

Detalles Bibliográficos
Autor principal: Adams, Charleen D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020919/
https://www.ncbi.nlm.nih.gov/pubmed/32103921
http://dx.doi.org/10.2147/CIA.S239350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020919/
https://www.ncbi.nlm.nih.gov/pubmed/32103921
http://dx.doi.org/10.2147/CIA.S239350

Ejemplares similares